Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOREMIFENE vs TRALOKINUMAB-LDRM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOREMIFENE vs TRALOKINUMAB-LDRM: Safety Overview

Metric TOREMIFENE TRALOKINUMAB-LDRM
Total FAERS Reports 245 4,116
Deaths Reported 16 57
Death Rate 6.5% 1.4%
Hospitalizations 92 239
Average Patient Age 61.7 yrs 50.5 yrs
% Female Patients 95.0% 61.8%
FDA Approval Date Aug 18, 2020 N/A
Manufacturer Kyowa Kirin, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A